MPU vs NAMI

MPU exhibits critical financial distress, highlighted by a Piotroski F-Score of 1/9, indicating severe fundamental weakness. The company is suffering from a massive revenue collapse (-49.20% YoY) and extreme operational inefficiency with an operating margin of -376.36%. While the current ratio of 4.06 suggests short-term liquidity, the combination of a 0/100 technical trend and consistent earnings misses points to a failing business model. The stock is in a long-term structural decline, losing over 72% of its value over the last five years.

NAMI presents a contradictory profile with a stable Piotroski F-Score of 5/9 and a very clean balance sheet, yet it is plagued by severe value destruction. The stock has collapsed over 82% in the last year and nearly 88% over five years, signaling a complete lack of market confidence. While the Price-to-Sales ratio of 0.10 suggests extreme undervaluation, the negative profit margins and stagnant revenue growth (5.3%) indicate a potential value trap. The absence of analyst coverage and a bearish technical trend (0/100) further reinforce a high-risk outlook.